I still insist that patents that are filed as a result of collaborations with PS Targeting and learning new facts, new knowledge .....that IS NOT common knowledge ..etc etc may have to give some rights back to Peregrine and I hope Peregrine can see whom they gave PS Targeting info to and patents filed soon after must be monitored ...and questioned how such info would be known if it were not for PS Targeting knowledge and seeing which BIOMARKERS to concentrate on...etc
So tell me this... Epinotis and Precision For Medicine both working with Peregrine and Biomarkers must have been seen and Bird&Bird advised PFM to buy out Epiontis.....
So what Biomarkers were seen and by whom ?? Because Berkshire etc as of 5 days ago are now loading up close to $300M to back PFM next phase ....
Peregrine Board of Directors.....you guys just watching the ball drop tonight and best not be dropping the ball on seizing all that Biomarker data that was ONLY possible to be seen via PS Targeting
Happy New Year to Precision For Medicine and has Peregrine been analyzing all those Biomarkers ??